Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous anesthesia dosing with propofol and remifentanil in obese vs normal-weight patients
2008-000537-22Phase 4Active
- Sponsor
- Hôpital Foch
- Start
- May 2008
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol and remifentanil (2 arms), sponsored by Hôpital Foch. Primary endpoint: Dose of propofol administered intraoperatively. Started May 2008; status: active.
02
Drugs
propofolremifentanil
Beyond the preview
Go deeper on 2008-000537-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000537-22.